Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
Parasit Vectors. 2024 Jun 28;17(1):276. doi: 10.1186/s13071-024-06347-w.
ABSTRACT
BACKGROUND: Female Aedes aegypti mosquitoes can spread disease-causing pathogens when they bite humans to obtain blood nutrients required for egg production. Following a complete blood meal, host-seeking is suppressed until eggs are laid. Neuropeptide Y-like receptor 7 (NPYLR7) plays a role in endogenous host-seeking suppression and previous work identified small-molecule NPYLR7 agonists that inhibit host-seeking and blood-feeding when fed to mosquitoes at high micromolar doses.
METHODS: Using structure-activity relationship analysis and structure-guided design we synthesized 128 compounds with similarity to known NPYLR7 agonists.
RESULTS: Although in vitro potency (EC50) was not strictly predictive of in vivo effect, we identified three compounds that reduced blood-feeding from a live host when fed to mosquitoes at a dose of 1 μM-a 100-fold improvement over the original reference compound.
CONCLUSIONS: Exogenous activation of NPYLR7 represents an innovative vector control strategy to block mosquito biting behavior and prevent mosquito-human host interactions that lead to pathogen transmission.
PMID:38937807 | DOI:10.1186/s13071-024-06347-w
![Google](https://www.google.com/images/branding/googlelogo/2x/googlelogo_light_color_92x30dp.png)
![Google Keep](https://www.gstatic.com/images/branding/product/1x/keep_48dp.png)
![Share on Linkedin](https://psychiatryai.com/wp-content/uploads/2023/10/linkedin-logo-png-2048-1.png)
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Cool Evidence: Engaging Young People and Students in Real-World Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Real-Time Evidence Search [Psychiatry]
![](/wp-content/uploads/2024/04/pubmed.png)
AI Research
![](/wp-content/uploads/2024/05/Il5nR_nf_400x400-modified-1.png)
Next-generation neuropeptide Y receptor small-molecule agonists inhibit mosquito-biting behavior
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
Suicidal Thoughts and Self-injurious Behavior Associated With Glucagon-Like Peptide-1 Receptor Agonists - A Review PPARs (Peroxisome Proliferator-activated Receptors) and Their Agonists in Alzheimer's Disease Identification of 1,3,8-triazaspiro[4.5]decane-2,4-dione Derivatives as a Novel Delta Opioid Receptor-Selective Agonist Chemotype Discovery of 3-((4-Benzylpyridin-2-yl)amino)benzamides as Potent GPR52 G Protein-Biased Agonists Inhibition of neuraminidase-1 sialidase activity by interfering peptides impairs insulin receptor activity in vitro and glucose homeostasis in vivo Postoperative use of sleep aids and delirium in older adults after major surgery: A retrospective cohort study Cholecystokinin B receptor agonists alleviates anterograde amnesia in cholecystokinin-deficient and aged Alzheimer's disease mice Underlying mechanisms for psychotropic effects of delta opioid receptor agonists A µ-opioid receptor modulator that works cooperatively with naloxone Structural pharmacology and therapeutic potential of 5-methoxytryptamines Structural pharmacology and therapeutic potential of 5-methoxytryptamines The effect of education regarding treatment guidelines for schizophrenia and major depressive disorders on psychiatrists' hypnotic medication prescribing behavior: a multicenter study International Union of Basic and Clinical Pharmacology CXIV: Orexin Receptor Function, Nomenclature and Pharmacology International Union of Basic and Clinical Pharmacology CXIV: Orexin Receptor Function, Nomenclature and Pharmacology P-glycoprotein activity in vivo in older adults: physiological, pathophysiological and pharmacokinetic interplay at the blood-brain barrier Neural circuits expressing the serotonin 2C receptor regulate memory in mice and humans The emerging role of glucagon-like peptide-1 in binge eating The emerging role of glucagon-like peptide-1 in binge eating Efficacy in diet-induced obese mice of the hepatotropic, peripheral cannabinoid 1 receptor inverse agonist TM38837 Discriminative stimulus properties of Cannabis sativa terpenes in rats Functions and pharmacology of α2β2 nicotinic acetylcholine receptors; in and out of the shadow of α4β2 nicotinic acetylcholine receptors PPAR-γ agonists reactivate the ALDOC-NR2F1 axis to enhance sensitivity to temozolomide and suppress glioblastoma progression Diabetes drugs activate neuroprotective pathways in models of neonatal hypoxic-ischemic encephalopathy Chronic treatment with glucagon-like peptide-1 and glucagon receptor co-agonist causes weight loss-independent improvements in hepatic steatosis in mice with diet-induced obesity Semaglutide combined with empagliflozin vs. monotherapy for non-alcoholic fatty liver disease in type 2 diabetes: Study protocol for a randomized clinical trial Biguanides and glucagon like peptide 1 receptor agonists in the amelioration of post liver transplant weight gain; a scoping review of the mechanism of action, safety and efficacy Impulse control disorders and use of dopamine agonists in early onset Parkinson's disease Impulse control disorders and use of dopamine agonists in early onset Parkinson's disease Impulse control disorders and use of dopamine agonists in early onset Parkinson's disease Development of novel tools for dissection of central versus peripheral dopamine D2-like receptor signaling in dysglycemia Development of a genetically encoded sensor for probing endogenous nociceptin opioid peptide release Development of a genetically encoded sensor for probing endogenous nociceptin opioid peptide release The Alk receptor tyrosine kinase regulates Sparkly, a novel activity regulating neuropeptide precursor in the Drosophila central nervous system Ectonucleotidase Activity in Smooth Muscle Tissues of Rats with a Valproate Model of Autism DRD4 gene polymorphism and impulse control disorder induced by dopamine agonists in Parkinson's disease Elafibranor PPARα/δ Dual Agonist Ameliorates Ovalbumin-Induced Allergic Asthma Cerebellar damage with inflammation upregulates oxytocin receptor expression in Bergmann Glia Hypothermia as Potential Therapeutic Approach to Attenuating Soman-Induced Seizure, Neuropathology, and Mortality with an Adenosine A(1) Receptor Agonist and Body Cooling Hypothermia as Potential Therapeutic Approach to Attenuating Soman-Induced Seizure, Neuropathology, and Mortality with an Adenosine A(1) Receptor Agonist and Body Cooling The role of fatty acid-binding protein 5 and 7 on locomotor, anxiety and social behavior: Interaction with NMDA signaling The role of fatty acid-binding protein 5 and 7 on locomotor, anxiety and social behavior: Interaction with NMDA signaling Influence of glucagon-like peptide-1 receptor agonists on fat accumulation in patients with diabetes mellitus and non-alcoholic fatty liver disease or obesity: A systematic review and meta-analysis of randomized control trials Generative design of compounds with desired potency from target protein sequences using a multimodal biochemical language model Could GLP-1 Receptor Agonists like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions? Piceatannol: a renaissance in antibacterial innovation unveiling synergistic potency and virulence disruption against serious pathogens Evaluating the efficacy of GIPR agonists on non-alcoholic fatty liver disease: A Mediation Mendelian Randomization Study Selective Agonists of Thyroid Hormone Receptor Beta: Promising Tools for the Treatment of Nonalcoholic Fatty Liver Disease Preliminary Review Finds No Link Between GLP-1 Receptor Agonists and Suicidality Efficacy and tolerability of brexpiprazole - a new antipsychotic drug from the group of dopamine D2 receptor partial agonists Efficacy and tolerability of brexpiprazole - a new antipsychotic drug from the group of dopamine D2 receptor partial agonists Glucagon-like peptide receptor agonists and risk for depression Glucagon-like peptide receptor agonists and risk for depression Ketamine can produce oscillatory dynamics by engaging mechanisms dependent on the kinetics of NMDA receptors Mapping the molecular motions of 5-HT3 serotonin-gated channel by voltage-clamp fluorometry Incretin-based investigational therapies for the treatment of MASLD/MASH GLP-1 receptor agonists and weight loss in schizophrenia - past, present, and future Trace amine-associated receptor 1 (TAAR1) agonists for psychosis: protocol for a living systematic review and meta-analysis of human and non-human studies Preclinical in vitro and in vivo results of the new silk vista flow diverter with P8RI coating LXR agonism for CNS diseases: promises and challenges Alpha2 Agonist Use in Critically Ill Adults: A Focus on Sedation and Withdrawal Prevention Ventral tegmental area amylin receptor activation differentially modulates mesolimbic dopamine signaling in response to fat versus sugar Neurocognition and NMDAR co-agonists pathways in individuals with treatment resistant first-episode psychosis: a 3-year follow-up longitudinal study Morroniside delays the progression of non-alcoholic steatohepatitis by promoting AMPK-mediated lipophagy Cavbeta3 Contributes to the Maintenance of the Blood-Brain Barrier and Alleviates Symptoms of Experimental Autoimmune Encephalitis
Evidence Blueprint
Next-generation neuropeptide Y receptor small-molecule agonists inhibit mosquito-biting behavior
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
Next-generation neuropeptide Y receptor small-molecule agonists inhibit mosquito-biting behavior
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
Suicidal Thoughts and Self-injurious Behavior Associated With Glucagon-Like Peptide-1 Receptor Agonists - A Review PPARs (Peroxisome Proliferator-activated Receptors) and Their Agonists in Alzheimer's Disease Pharmacological and Physicochemical Properties Optimization for Dual-Target Dopamine D3 (D3R) and μ-Opioid (MOR) Receptor Ligands as Potentially Safer Analgesics Identification of 1,3,8-triazaspiro[4.5]decane-2,4-dione Derivatives as a Novel Delta Opioid Receptor-Selective Agonist Chemotype Discovery of 3-((4-Benzylpyridin-2-yl)amino)benzamides as Potent GPR52 G Protein-Biased Agonists Development of bile acid activated receptors hybrid molecules for the treatment of inflammatory and metabolic disorders NCP, a dual kappa and mu opioid receptor agonist, is a potent analgesic against inflammatory pain without reinforcing or aversive properties All-Hydrocarbon Stapled Peptide Multifunctional Agonists at Opioid and Neuropeptide FF Receptors: Highly Potent, Long-Lasting Brain Permeant Analgesics with Diminished Side Effects Experimental and computational biophysics to identify vasodilator drugs targeted at TRPV2 using agonists based on the probenecid scaffold Inhibition of neuraminidase-1 sialidase activity by interfering peptides impairs insulin receptor activity in vitro and glucose homeostasis in vivo Postoperative use of sleep aids and delirium in older adults after major surgery: A retrospective cohort study Discovery of a CB2 and 5-HT1A receptor dual agonist for the treatment of depression and anxiety The Effects of Chronic Naltrexone on Reinstatement of Opioid-Induced Drug-Seeking Behavior and Antinociception Miniseries: Established pharmacological targets for NASHFXR agonists in NASH treatment The future of incretins in the treatment of obesity and non-alcoholic fatty liver disease Mechanisms of biased agonism by Gαi/o-biased stapled peptide agonists of the relaxin-3 receptor Estradiol and Mu opioid-mediated reward: The role of estrogen receptors in opioid use Pistacia vera Extract Potentiates the Effect of Melatonin on Human Melatonin MT1 and MT2 Receptors with Functional Selectivity Cholecystokinin B receptor agonists alleviates anterograde amnesia in cholecystokinin-deficient and aged Alzheimer's disease mice Identification of 3H-benzo[b] [1,4] diazepine derivatives as PPARα agonists by in silico studies and biochemical evaluation Identification of drug repurposing candidates for the treatment of anxiety: A genetic approach µ-Opioid receptor antagonism facilitates the anxiolytic-like effect of oxytocin in mice Underlying mechanisms for psychotropic effects of delta opioid receptor agonists Discovery and in vitro Evaluation of Novel Serotonin 5-HT2A Receptor Ligands Identified Through Virtual Screening A µ-opioid receptor modulator that works cooperatively with naloxone Fasting upregulates the monocarboxylate transporter MCT1 at the rat blood-brain barrier through PPAR delta activation A retrospective clinical practice study comparing the usefulness of dual-orexin receptor antagonists and a melatonin receptor agonist in patients switching from long-term benzodiazepine receptor agonists Insomnia Management: A Review and Update Structural pharmacology and therapeutic potential of 5-methoxytryptamines Structural pharmacology and therapeutic potential of 5-methoxytryptamines The effect of education regarding treatment guidelines for schizophrenia and major depressive disorders on psychiatrists' hypnotic medication prescribing behavior: a multicenter study The antipsychotic medications aripiprazole, brexpiprazole and cariprazine are off-target respiratory chain complex I inhibitors International Union of Basic and Clinical Pharmacology CXIV: Orexin Receptor Function, Nomenclature and Pharmacology International Union of Basic and Clinical Pharmacology CXIV: Orexin Receptor Function, Nomenclature and Pharmacology P-glycoprotein activity in vivo in older adults: physiological, pathophysiological and pharmacokinetic interplay at the blood-brain barrier Neural circuits expressing the serotonin 2C receptor regulate memory in mice and humans Augmentation therapy with serotonin1A receptor partial agonists on neurocognitive function in schizophrenia: A systematic review and meta-analysis A MOR Antagonist with High Potency and Antagonist Efficacy among Diastereomeric C9-Alkyl-Substituted N-Phenethyl-5-(3-hydroxy)phenylmorphans The emerging role of glucagon-like peptide-1 in binge eating The emerging role of glucagon-like peptide-1 in binge eating Glucocorticoid receptor modulator CORT125385 alleviates diet-induced hepatosteatosis in male and female mice Synthesis and biochemical evaluation of 17-N-beta-aminoalkyl-4,5α-epoxynormorphinans Efficacy in diet-induced obese mice of the hepatotropic, peripheral cannabinoid 1 receptor inverse agonist TM38837 Melanocortin agonism in a social context selectively activates nucleus accumbens in an oxytocin-dependent manner Discriminative stimulus properties of Cannabis sativa terpenes in rats Sub-second Dopamine Signals during Risky Decision-Making in Patients with Impulse Control Disorder Functions and pharmacology of α2β2 nicotinic acetylcholine receptors; in and out of the shadow of α4β2 nicotinic acetylcholine receptors PPAR-γ agonists reactivate the ALDOC-NR2F1 axis to enhance sensitivity to temozolomide and suppress glioblastoma progression EPD1504: a novel μ-opioid receptor partial agonist attenuates obsessive-compulsive disorder (OCD)-like behaviors Possible involvement of FFAR1 signaling in mouse emotional behaviors through the regulation of brain monoamine releases Diabetes drugs activate neuroprotective pathways in models of neonatal hypoxic-ischemic encephalopathy Chronic treatment with glucagon-like peptide-1 and glucagon receptor co-agonist causes weight loss-independent improvements in hepatic steatosis in mice with diet-induced obesity 4-Amidophenol Quinone Methide Precursors: Effective and Broad-Scope Nonoxime Reactivators of Organophosphorus-Inhibited Cholinesterases and Resurrectors of Organophosphorus-Aged Acetylcholinesterase Semaglutide combined with empagliflozin vs. monotherapy for non-alcoholic fatty liver disease in type 2 diabetes: Study protocol for a randomized clinical trial Biguanides and glucagon like peptide 1 receptor agonists in the amelioration of post liver transplant weight gain; a scoping review of the mechanism of action, safety and efficacy Optogenetic determination of dynamic and cell-type-specific inhibitory reversal potentials GFP and FAP imaging of neuropeptide release in Drosophila Impulse control disorders and use of dopamine agonists in early onset Parkinson's disease Impulse control disorders and use of dopamine agonists in early onset Parkinson's disease Impulse control disorders and use of dopamine agonists in early onset Parkinson's disease hERG agonists pose challenges to web-based machine learning methods for prediction of drug-hERG channel interaction Discovery of LH10, a novel fexaramine-based FXR agonist for the treatment of liver disease Sex differences and sex-specific regulation of motivated behavior by Melanin-concentrating hormone: a short review Neuronal diversity of neuropeptide signaling, including galanin, in the mouse locus coeruleus